The manufacturer of the painkiller OxyContin is trying to extend its exclusive rights to the drug, which is set to go off patent in 2013, The Wall Street Journal reports. Purdue Pharma LP says a reformulated version of the drug may substantially decrease abuse of the opioid.
The company points to a 22 percent decline in the street price of the drug from 2010 to 2011, as evidence the new formulation is cutting down on abuse. The number of visits to poison control centers and admissions to addiction treatment programs due to OxyContin have also declined since the drug was reformulated, they said.
Source: JoinTogether.org – June 28, 2012